Atlas Trials

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Clinical trial NCT00634634 · COMPLETED

Trial details

NCT number
NCT00634634
Sponsor
Rutgers, The State University of New Jersey
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2008-08-11
Primary completion
2019-04-20
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.